OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States
Hailey J. Park, Gregg Gonsalves, Sophia T. Tan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Hailey J. Park, Gregg Gonsalves, Sophia T. Tan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 2
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 2
Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom
Cale Harrison, Rebecca Butfield, Benjamin Yarnoff, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 730-739
Open Access | Times Cited: 1
Cale Harrison, Rebecca Butfield, Benjamin Yarnoff, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 730-739
Open Access | Times Cited: 1
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis
Stéphane Le Vu, Marion Bertrand, Laura Semenzato, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Stéphane Le Vu, Marion Bertrand, Laura Semenzato, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naïve nursing home residents
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Comparative Analysis of Adverse Event Rates and Severity Following COVID-19 mRNA Vaccinations Among SARS-CoV-2 Naïve Nursing Home Residents and Staff
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Research Square (Research Square) (2024)
Open Access
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Research Square (Research Square) (2024)
Open Access
Assessment of COVID-19 vaccine effectiveness in a nation with a low vaccination coverage: insights from real-world data and propensity score matched analyses
G Dimitrov, Krassimir Kalinov, Trifon Valkov
Biotechnology & Biotechnological Equipment (2024) Vol. 38, Iss. 1
Open Access
G Dimitrov, Krassimir Kalinov, Trifon Valkov
Biotechnology & Biotechnological Equipment (2024) Vol. 38, Iss. 1
Open Access
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Giulia Vivaldi, Mohammad Talaei, Paul E Pfeffer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Giulia Vivaldi, Mohammad Talaei, Paul E Pfeffer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Optimal annual COVID-19 vaccine boosting dates following previous booster vaccination or breakthrough infection
Jeffrey P. Townsend, Hayley B. Hassler, Alex Dornburg
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Jeffrey P. Townsend, Hayley B. Hassler, Alex Dornburg
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents
Eddy Fadlyana, Kusnandi Rusmil, Muhammad Gilang Dwi Putra, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 938-938
Open Access
Eddy Fadlyana, Kusnandi Rusmil, Muhammad Gilang Dwi Putra, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 938-938
Open Access
The WHO Algorithm for Causality Assessment of Adverse Effects Following Immunization with Genetic-Based Anti-COVID-19 Vaccines: Pitfalls and Suggestions for Improvement
Paolo Bellavite, Alberto Donzelli, Ciro Isidoro
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7291-7291
Open Access
Paolo Bellavite, Alberto Donzelli, Ciro Isidoro
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7291-7291
Open Access
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer
Amy Body, Luxi Lal, Sriganesh Srihari, et al.
Vaccine (2024), pp. 126547-126547
Open Access
Amy Body, Luxi Lal, Sriganesh Srihari, et al.
Vaccine (2024), pp. 126547-126547
Open Access
Tiled Amplicon Sequencing Enables Culture-free Whole-Genome Sequencing of Pathogenic Bacteria From Clinical Specimens
Chaney C. Kalinich, Freddy L. Gonzalez, Alice Osmaston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Chaney C. Kalinich, Freddy L. Gonzalez, Alice Osmaston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
